Amanote Research

Amanote Research

    RegisterSign In

Second Dose of Measles, Mumps, and Rubella Vaccine: Questionnaire Survey of Health Professionals

BMJ
doi 10.1136/bmj.322.7278.82
Full Text
Open PDF
Abstract

Available in full text

Date

January 13, 2001

Authors
M. Petrovic
Publisher

BMJ


Related search

Measles, Mumps and Rubella Vaccine

Drugs and Therapy Perspectives
Pharmacology
1993English

Economic Benefits of a Routine Second Dose of Combined Measles, Mumps and Rubella Vaccine in Canada

Canadian Journal of Infectious Diseases
1997English

Measles, Mumps and Rubella

2010English

Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine — Illinois, 2015–2016

MMWR. Morbidity and mortality weekly report
Health Information ManagementMutagenesisEpidemiologyHealthMedicineToxicology
2016English

Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures

Pediatrics
Child HealthPediatricsPerinatology
2010English

Effectiveness of Measles, Mumps and Rubella Vaccine as Immunotherapeutic Agent for Cutaneous Viral Warts

International Journal of Research in Dermatology
2020English

Factors Affecting Uptake of Measles, Mumps, and Rubella Immunisation.

BMJ
1993English

Pancreatic Pseudocyst After Measles, Mumps, and Rubella Vaccination

Turkish Journal of Gastroenterology
Gastroenterology
2017English

Intralesional Measles, Mumps and Rubella (Mmr) Vaccine - An Effective Therapeutic Tool in the Treatment of Wart

Journal of Evidence Based Medicine and Healthcare
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy